SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-137193
Filing Date
2021-04-28
Accepted
2021-04-28 17:27:00
Documents
5
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d146195ddef14a.htm DEF 14A 300629
2 GRAPHIC g146195g02v34.jpg GRAPHIC 31594
3 GRAPHIC g146195g08c20.jpg GRAPHIC 36896
4 GRAPHIC g146195g35v35.jpg GRAPHIC 167103
5 GRAPHIC g146195g36v36.jpg GRAPHIC 133088
  Complete submission text file 0001193125-21-137193.txt   803393
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36183 | Film No.: 21865702
SIC: 2836 Biological Products, (No Diagnostic Substances)